HSIC — HENRY SCHEIN INC
Health Care · Medical Distribution
InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.
Sourced from SEC EDGAR public filings
Why are billionaires buying HSIC?
Built from public SEC filings and public economic data. Not a recommendation.
Why? — Evidence & Confidence ▾
Of 3 tracked investors who changed their HSIC position last quarter, 3 bought and 0 sold (100% buy-side). Macro conditions are mixed for this sector (Macro Tailwind 55/100 in a Squeeze regime).
- +3 tracked investors added or increased positions last quarter (David Einhorn, Paul Tudor Jones, Ray Dalio)
- +6 tracked investors reported holding HSIC at their latest filing
- +Macro Health is 52/100 in a Squeeze regime — historically acceptable for Health Caresource
- −13F data is disclosed up to 45 days after quarter end — positions may have changed since
- · 13F disclosure lag (up to 45 days)
- · Tracked investors are a sample, not the whole market
- · Sector regime fit is a historical average, not a guarantee
Every InvestorLens score shows its evidence — including what argues against it. Model conviction-v1 · generated 8/4/2026.
About HENRY SCHEIN INC (HSIC)
HENRY SCHEIN INC (HSIC) appears in the most recent 13F filings of 6 tracked institutional investors. HENRY SCHEIN INC is classified in the Health Care sector (Medical Distribution industry). The largest disclosed position is held by David Einhorn (DME Capital Management, LP), valued at $44M. Across recent filings, tracked investors recorded 6 new positions, 0 increased, 0 reduced, and 1 exited. All data sourced from SEC 13F filings.
Based on recent institutional activity in HSIC
How many top investors track HSIC
Several tracked investors have exposure.
HSIC Ownership Composition
How HENRY SCHEIN INC is held across tracked investor types, based on reported 13F positions.
- Hedge Funds76.3%
- Other23.7%
Tracked investors reporting HSIC
- David EinhornMar 31, 2026DME Capital Management, LPShares599.3KValue$44.2M% Portfolio1.38%
- Ken GriffinMar 31, 2026Citadel AdvisorsShares63.5KValue$4.7M% Portfolio0.00%
- Steve CohenDec 31, 2025Point72 Asset ManagementShares250KValue$18.9M% Portfolio0.02%
- Izzy EnglanderMar 31, 2026Millennium ManagementShares165.7KValue$12.2M% Portfolio0.01%
- Paul Tudor JonesMar 31, 2026Tudor Investment CorpShares4.2KValue$310.3K% Portfolio0.00%
- Ray DalioMar 31, 2026Bridgewater AssociatesShares32.1KValue$2.4M% Portfolio0.01%
Recent activity
- $35.5MFeb 17, 2026
- $44.2MMay 15, 2026
- $6.8MFeb 17, 2026
- $310.3KMay 15, 2026
- New$2.4MMay 15, 2026
- Sold$0(-100.00%)Feb 13, 2026
- New$230.2KNov 13, 2025
Frequently asked questions
- How many institutional investors hold HSIC?
- 6 tracked institutional investors disclosed a position in HSIC (HENRY SCHEIN INC) in their most recent 13F filing.
- Who is the largest institutional holder of HSIC?
- David Einhorn, DME Capital Management, LP, holds the largest disclosed position in HSIC, valued at $44M.
- Did institutional ownership of HSIC increase or decrease?
- Across recent 13F filings, tracked investors recorded 6 new positions, 0 increased, 0 reduced, and 1 fully exited HSIC.
- What sector is HSIC in?
- HENRY SCHEIN INC is classified in the Health Care GICS sector, Medical Distribution industry.
- Where does this HSIC ownership data come from?
- SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.